col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


69 Results       Page 1

 [1] 
Mary Ann Liebert: Viral Immunology
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―13 Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells, NLRP3, and Lactate Dehydrogenase in Severe/Critical COVID-19: A Prospective Longitudinal Study According to the Severe/Critical COVID-19 Definitions Maedeh Radandish, Nafiseh Esmaeil, Farzin Khorvash, Alireza Andalib
2 [GO] 2022―Aug―23 Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity Majid Khoshmirsafa, Mohammad-Ali Assarehzadegan, Morteza Fallahpour, Maryam Azimi, Fatemeh Faraji, Taghi Riahi, et al. (+4)
3 [GO] 2022―Aug―11 Detection of the Serum Cytokines Predicts COVID-19 Pathogenesis in Egyptian Patients Lamiaa Mobarak, Mohamed Shemis, Raghda Samir Abdellatif, Amina Fouad, Mostafa H. Elberry, Reham M. Dawood
4 [GO] 2022―Aug―05 The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients Eman Z. Kandeel, Lobna Refaat, Ahmed Bayoumi, Hend A. Nooh, Reham Hammad, Medhat Khafagy, Mona S. Abdellateif
5 [GO] 2022―Aug―03 Hybrid Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Rodney S. Russell
6 [GO] 2022―Jul―20 Response to Sriwijitalai and Wiwanitkit re “Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T and COVID-19: A Correspondence” Amirmasoud Rayati Damavandi, Farshid Fathi, Nahid Eskandari
7 [GO] 2022―Jul―20 Re: “Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T and COVID-19: A Correspondence” by Rayati Damavandi et al. Won Sriwijitalai, Viroj Wiwanitkit
8 [GO] 2022―Jul―20 SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination Tom Moore, Rojony Hossain, Katie J. Doores, Manu Shankar-Hari, David J. Fear
9 [GO] 2022―Jun―29 SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections Sepideh Meidaninikjeh, Nasim Sabouni, Mahdie Taheri, Mahdis Borjkhani, Sajad Bengar, Naime Majidi Zolbanin, et al. (+2)
10 [GO] 2022―May―17 Letter to the Editor: The Clinical Features of SARS-CoV-2 Infection Are Becoming Milder with Limited Symptomatic Effects Katia Margiotti, Marco Fabiani, Alvaro Mesoraca, Claudio Giorlandino
11 [GO] 2022―May―05 The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study Amirmasoud Rayati Damavandi, Parnian Zolfaghari Baghbadorani, Bahareh Kardideh, Hamed Fouladseresht, Marjan Golabi, Behrooz Ghezelbash, et al. (+4)
12 [GO] 2022―Apr―21 The Role of Immune Regulatory Molecules in COVID-19 Zahra Khalifehzadeh-Esfahani, Soheila Fattahi, Zahra Heidari Haratemeh, Morteza Jafarinia
13 [GO] 2022―Apr―01 The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis Eren Cagan, Gulcin Tezcan, Abdurrahman Simsek, Muhammed Ali Kizmaz, Fatma Dombaz, Ali Asan, et al. (+8)
14 [GO] 2022―Mar―25 Clinical Characteristics of COVID-19 Patients' Postvaccination Xiao-Bin Zhang, Si-Jiu Yang, Yong Lin, Li-Li Chen, Ya-Li Zhuang, Hui-Qing Zeng
15 [GO] 2022―Mar―24 Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review K.P. Mishra, Mrinalini Singh, Deepika Saraswat, Lilly Ganju, Rajeev Varshney
16 [GO] 2022―Mar―15 Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-2 Akane Takamatsu, Satoshi Oshiro, Naeko Mizutani, Tatsuya Tada, Yoko Tabe, Takashi Miida, et al. (+2)
17 [GO] 2022―Mar―14 Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19 Maggie L. Bartlett, San Suwanmanee, Nadine Peart Akindele, Shristi Ghimire, Andy K.P. Chan, Chenxu Guo, et al. (+3)
18 [GO] 2022―Feb―23 Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases Ahmet Cizmecioglu, Ayca Emsen, Sua Sumer, Dilek Ergun, Hilal Akay Cizmecioglu, Hatice Turk Dagi, Hasibe Artac
19 [GO] 2022―Feb―15 Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients Hafsa Aziz, Shazia Fatima, Humera Mahmood, Shahkhalid Muhammad, Mohammad Adnan Saeed, Shaista Khurshid, et al. (+3)
20 [GO] 2022―Feb―15 Assessment of S-Specific IgG and IgM Positive Rates in Healthy Hospital Staff Members Vaccinated with the Inactivated SARS-CoV-2 Vaccine Lijun Zhou, Dabin Liu, Huihua Zhang, Limei Wu, Xuehui Liu, Xiaoyan Wang, et al. (+4)
21 [GO] 2022―Feb―10 Do Sputnik V Vaccine-Induced Antibodies Protect Against Seasonal Coronaviruses? Case Study Maksim Koryukov, Andrey Kechin, Darya Shamovskaya, Anna Timofeeva, Maxim Filipenko
22 [GO] 2022―Feb―09 Occurrence and Associated Risk Factors of Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus Type 2 Infections in Greece Vasileios G. Papatsiros, Georgios Papakonstantinou, Eletherios Meletis, Nikolaos Tsekouras, Giorgos Maragkakis, Dimitra Bitchava, Polychronis Kostoulas
23 [GO] 2022―Jan―27 Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6 Fanny Ponthieux, Nicolas Dauby, Evelyne Maillart, Jean-François Fils, Julie Smet, Marc Claus, et al. (+4)
24 [GO] 2022―Jan―12 COVID-19: Testing Landscape Post-Infection, -Vaccination, and Future Perspectives Maite Sabalza, Ilana Heckler, Aya Elhage, Iswariya Venkataraman, Brandon Henry
25 [GO] 2022―Jan―10 Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Poonam S. Deshpande, Irene E. Abraham, Anjali Pitamberwale, Radhika H. Dhote
26 [GO] 2021―Dec―22 Generation and Evaluation of Recombinant Baculovirus Coexpressing GP5 and M Proteins of Porcine Reproductive and Respiratory Syndrome Virus Type 1 Wang Xu, Shouwen Du, Tiyuan Li, Shipin Wu, Ningyi Jin, Linzhu Ren, Chang Li
27 [GO] 2021―Dec―14 Controlling the Burden of COVID-19 by Manipulating Host Metabolism Logan Miller, Engin Berber, Deepak Sumbria, Barry T. Rouse
28 [GO] 2021―Dec―09 Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective Amirhossein Mardi, Sepideh Meidaninikjeh, Sepideh Nikfarjam, Naime Majidi Zolbanin, Reza Jafari
29 [GO] 2021―Dec―09 Correction to: The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses by Ramírez Hernández et al. Viral Immunol. 2021;34(3):165-173. DOI: 10.1089/vim.2020.0174.
30 [GO] 2021―Nov―08 A Single Dose of SARS-CoV-2 Vaccine Primes a Strong Humoral Immune Response in COVID-19-Recovered Patients Waleed H. Mahallawi, Mohamed H. Fakher, Mohammad A. Alsarani, Rami H. Aljohani, Salah A. AL-Mutabgani, Nadir A. Ibrahim
31 [GO] 2021―Oct―21 Response to Mishra et al. re “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” Martin Krsak, Brian L. Harry, Brent E. Palmer, Carlos Franco-Paredes
32 [GO] 2021―Oct―21 Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al. Bijaya Kumar Mishra, Debdutta Bhattacharya, Jaya Singh Kshatri, Sanghamitra Pati
33 [GO] 2021―Sep―17 Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients Faezeh Maghsood, Danesh Hassani, Vahid Salimi, Gholam Ali Kardar, Jalal Khoshnoodi, Abbas Ghaderi, et al. (+8)
34 [GO] 2021―Sep―16 Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19 Carlos Jiménez-Cortegana, Julia Liró, Natalia Palazón-Carrión, Elena Salamanca, Jesús Sojo-Dorado, Luis de la Cruz-Merino, et al. (+3)
35 [GO] 2021―Sep―07 Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al. [Epub ahead of print]; DOI: 10.1089/vim.2021.0054 Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
36 [GO] 2021―Sep―07 Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider? Cosby G. Arnold, Andrew A. Monte, Katherine Littlefield, Alexis Vest, Brent E. Palmer
37 [GO] 2021―Aug―13 Levamisole Therapy in COVID-19 Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Athanasios Alexiou, Gaber El-Saber Batiha
38 [GO] 2021―Jul―23 Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages Chenghao Huang
39 [GO] 2021―Jul―06 Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2 Martin Krsak, Brian L. Harry, Brent E. Palmer, Carlos Franco-Paredes
40 [GO] 2021―Jun―11 Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 Mariana Avendaño-Félix, Luis Antonio Ochoa-Ramírez, Rosalío Ramos-Payán, Maribel Aguilar-Medina, Alfredo Ayala-Ham, Horacio Rendón-Aguilar, et al. (+4)
41 [GO] 2021―Jun―08 An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay Haseeb Ahsan, Jong Kyung Sonn, Young Sup Lee, Salman Ul Islam, Saifullah Khan Khalil
42 [GO] 2021―May―21 CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19 Mengyuan Yang, Zhiyu Liu, Kai Kang, Kaijiang Yu, Changsong Wang
43 [GO] 2021―May―21 Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets Noha A. Kamel, Lamia M. El Wakeel, Khaled M. Aboshanab
44 [GO] 2021―May―17 Herd Immunity Against COVID-19: More Questions Than Answers Rodney S. Russell
45 [GO] 2021―May―13 Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis Anthony R. Mawson, Ashley M. Croft, Federico Gonzalez-Fernandez
46 [GO] 2021―Apr―27 The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes Lixia Xie, Yuanlan Lin, Yushu Deng, Bin Lei
47 [GO] 2021―Mar―19 Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador Robert Needle, Laura Gilbert, George Zahariadis, Yang Yu, Hedy Dalton-Kenny, Rodney S. Russell, et al. (+4)
48 [GO] 2021―Feb―24 T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications Juan Camilo Sarmiento-Monroy, Rafael Parra-Medina, Edgar Garavito, Adriana Rojas-Villarraga
49 [GO] 2021―Feb―19 The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses Eleazar Ramírez Hernández, Luis Fernando Hernández-Zimbrón, Nayeli Martínez Zúñiga, Juan José Leal-García, Violeta Ignacio Hernández, Luis Eduardo Ucharima-Corona, et al. (+2)
50 [GO] 2021―Jan―22 Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology Ashutosh Kumar, Sujeet Kumar, Ravi K. Narayan, Chiman Kumari, Vikas Pareek, Pranav Prasoon
51 [GO] 2020―Dec―22 How to Understand Herd Immunity in the Context of COVID-19 Minghao Dong, Feng He, Yu Deng
52 [GO] 2020―Dec―02 Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19 Sumeyye Kazancioglu, Fatma Meric Yilmaz, Aliye Bastug, Arzu Sakallı, Bahadır Orkun Ozbay, Cansu Buyuktarakci, et al. (+2)
53 [GO] 2020―Dec―02 COVID-19 Infection: Data Gaps for Diagnostic Laboratory Preparedness and Tasks on Hand Subrata Biswas, Piyali Ghosh, Debjit Chakraborty, Ananya Chatterjee, Shanta Dutta, Malay Kumar Saha
54 [GO] 2020―Nov―17 Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19 Yang Gao, Changsong Wang, Kai Kang, Yahui Peng, Yunpeng Luo, Haitao Liu, et al. (+3)
55 [GO] 2020―Nov―12 Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-γ as a Novel Antiviral Approach Against COVID-19 Faisal Rasheed Anjum, Sidra Anam, Ghazanfar Abbas, Muhammad Shahid Mahmood, Sajjad ur Rahman, Mohsan Ullah Goraya, et al. (+5)
56 [GO] 2020―Nov―12 COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies Martin Krsak, Andrés F. Henao-Martínez, Carlos Franco-Paredes
57 [GO] 2020―Nov―04 Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons Abdollah Jafarzadeh, Maryam Nemati, Bhaskar Saha, Yashwant D. Bansode, Sara Jafarzadeh
58 [GO] 2020―Oct―05 Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients Sadegh Safaei, Masoud Karimi-Googheri
59 [GO] 2020―Oct―05 COVID-19: Between Past and Present Areej M. Assaf, Randa N. Haddadin, Amal A. Akour
60 [GO] 2020―Sep―28 Coronavirus Disease 2019 Vaccine Development: An Overview Riyadi Sumirtanurdin, Melisa Intan Barliana
61 [GO] 2020―Aug―28 Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection? Nidhi Maheshwari, Ayush Jain
62 [GO] 2020―Jul―02 Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs Ruiyi Zhang, Yanmei Tang
63 [GO] 2020―Jun―09 Call for Papers: Special Issue on Coronaviruses Rodney Russell
64 [GO] 2020―May―13 Call for Papers: Special Issue on Coronaviruses Rodney Russell
65 [GO] 2020―Apr―29 B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020 Julia L. Hurwitz
66 [GO] 2020―Apr―27 Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis José Valter Joaquim Silva Júnior, Thaísa Regina Rocha Lopes, Pablo Sebastian Britto de Oliveira, Rudi Weiblen, Eduardo Furtado Flores
67 [GO] 2020―Apr―16 Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 Yang Liu, Wenjian Liao, Lagen Wan, Tianxing Xiang, Wei Zhang
68 [GO] 2020―Apr―14 Peter's Paradigm and Pandemic Preparedness Maryna C. Eichelberger
69 [GO] 2020―Apr―06 Call for Papers: Special Issue on Coronaviruses
 [1] 

69 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.010 sec